Publication Name	World Journal of Gastroenterology
Manuscript ID	8046
Country	South Korea

Received	2013-12-12 17:07
Peer-Review Started	2013-12-13 08:36
To Make the First Decision	2013-12-26 11:14
Return for Revision	2013-12-27 16:26
Revised	2014-01-08 10:20
Second Decision	2014-02-27 11:23
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-02-27 11:25
Articles in Press	2014-05-23 09:17
Publication Fee Transferred
Edit the Manuscript by Language Editor	2014-04-04 16:43
Typeset the Manuscript	2014-05-22 15:47
Publish the Manuscript Online	2014-06-16 16:19

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Autobiography
Article Title	Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South Korea
Manuscript Source	Unsolicited Manuscript
All Author List	Kyu Keun Kang, Dong Ho Lee, Dong Hyun Oh, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Nayoung Kim and Hyun Chae Jung
Funding Agency and Grant Number
Corresponding Author	Dong Ho Lee, PhD, Department of Internal Medicine, Seoul National University Bundang Hospital, 300 Gumi-dong, Bundang-gu, Seongnam-si, Gyeongi-do 463-707, South Korea. dhljohn@yahoo.co.kr
Key Words	Fluoroquinolones; Helicobacter pylori; Disease eradication; Drug resistance; Second-line
Core Tip	This study aimed to examine Helicobacter pylori (H. pylori) eradication rates using moxifloxacin-containing triple therapy as second-line treatment. The effectiveness of the failed first-line treatment options was compared. The use of moxifloxacin-containing triple therapy resulted in low eradication rates, and there were no differences in the efficacy between the failed first-line regimens. As a result, we recommend tailored therapy for H. pylori and careful antibiotic selection before second-line treatment in South Korea.
Publish Date	2014-06-16 16:19
Citation	Kang KK, Lee DH, Oh DH, Yoon H, Shin CM, Park YS, Kim N, Jung HC. Helicobacter pylori eradication with moxifloxacin-containing therapy following failed first-line therapies in South korea. World J Gastroenterol 2014; 20(22): 6932-6938
URL	http://www.wjgnet.com/1007-9327/full/v20/i22/6932.htm
DOI	10.3748/wjg.v20.i22.6932

Full Article (PDF)	WJG-20-6932.pdf
Full Article (Word)	WJG-20-6932.doc
Manuscript File	8046-Review.docx
Answering Reviewers	8046-Answering reviewers.pdf
Copyright License Agreement	8046-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	8046-Language certificate.pdf
Peer-review Report	8046-Peer review(s).pdf
Scientific Editor Work List	8046-Scientific editor work list.doc